News

Filter

Current filters:

ZometaDiovan

1 to 9 of 36 results

Overview of Novartis' patent losses from GlobalData

11-10-2012

Swiss drug major Novartis (NOVN: VX) is the latest victim of patent protection loss, note analysts at…

DiovanFemaraFinancialGleevecNovartisPatentsPharmaceuticalReclastZometa

Novartis speeds R&D ahead of Diovan loss

12-01-2009

Swiss drug major Novartis says it is taking a multi-faceted approach to help cushion it from the effects…

Aliskiren TabletsDiovanNovartisTekturnavalsartanzoledronic acidZometa

Novartis profit up 32% in 3rd qtr

27-10-2008

Swiss drug major Novartis' profit grew 32% in the third quarter of 2008, versus the same period of the…

Aliskiren TabletsAmlodipine and ValsartanDiovanExforgeFemaraGleevecImatinib MesylateLetrozoleNovartisSandozTekturnavalsartanzoledronic acidZometa

Novartis expands ophthalmics franchise with 25% stake in Alcon, plus more later

14-04-2008

Pharmaceutical major Novartis has entered into an agreement with fellow Switzerland-based food giant…

AlconDiovanGenentechLucentisNovartisRanibizumab InjectionvalsartanVerteporfin InjVisudynezoledronic acidZometa

1 to 9 of 36 results

COMPANY SPOTLIGHT

Menarini

Back to top